Zocor and Injection site nodule - a phase IV clinical study of FDA data

Summary:

Injection site nodule is reported as a side effect among people who take Zocor (simvastatin), especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years also take Bydureon, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Injection site nodule when taking Zocor. It is created by eHealthMe based on reports of 84,616 people who have side effects when taking Zocor from the FDA, and is updated regularly.

What is Zocor?

Zocor has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 86,545 Zocor users. Check the latest studies of Zocor.

What is Injection site nodule?

Injection site nodule (small swelling or aggregation of cells in the body, esp. an abnormal one at injection site) is found to be associated with 423 drugs and 588 conditions by eHealthMe. Check the latest studies of Injection site nodule.

On Jul, 14, 2026

84,616 people reported to have side effects when taking Zocor.
Among them, 48 people (0.06%) have Injection site nodule.

Could Zocor cause Injection site nodule?

Among these 48 people:

How long have people been on Zocor when they have Injection site nodule? *

What is the gender of people who have Injection site nodule when taking Zocor? *

female: 50 %
male: 50 %

What is the age of people who have Injection site nodule when taking Zocor? *

What are other drugs people take besides Zocor? *

What are other side effects people have besides Injection site nodule? *

Injection Site Pain: 18 people, 37.50%
Injection Site Erythema (redness at injection site): 15 people, 31.25%
Injection Site Pruritus (severe itching at injection site): 11 people, 22.92%
Nausea (feeling of having an urge to vomit): 6 people, 12.50%
Drug Ineffective: 5 people, 10.42%
Injection Site Extravasation (flow of (blood or lymph) from injection site): 5 people, 10.42%
Injection Site Haemorrhage (bleeding from injection site): 5 people, 10.42%
Injection Site Mass: 5 people, 10.42%
Injection Site Warmth: 5 people, 10.42%
Injection Site Swelling: 5 people, 10.42%

What are the existing conditions these people have? *

Type 2 Diabetes: 21 people, 43.75%
Diabetes: 8 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 12.50%
Osteoporosis (bones weak and more likely to break): 3 people, 6.25%
Blood Pressure Abnormal: 3 people, 6.25%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 6.25%
Neuropathy Peripheral (surface nerve damage): 2 people, 4.17%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 4.17%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 4.17%
Coronary Artery Occlusion (complete obstruction of blood flow in a coronary artery): 2 people, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Zocor and have Injection site nodule?

- Check whether Injection site nodule is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Zocor:

Zocor (86,545 reports)

Browse all side effects of Zocor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Injection site nodule:

Injection site nodule (423 drugs)

Browse all the conditions that are associated with Injection site nodule:

Injection site nodule (588 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on simvastatin (the active ingredients of Zocor) and Zocor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.